This is a worked review of a problem that shows up in blood draw rooms everywhere: light blue citrate tubes arriving at the laboratory clotted, and therefore rejected. The subject is a generalised one — a Winnipeg blood-draw clinic — and every figure below is a self-reported sample from that clinic's own tracking, presented as an example of the method, not as audited industry data. No organisation is named. The purpose is to show how a clinic can turn a vague complaint about "bad tubes" into a measured rate, a short list of causes, and a change it can verify in the next quarter.
What Was Actually Going Wrong?
The presenting complaint was familiar. Staff reported that citrate tubes occasionally "just clot", that repeat draws were annoying patients, and that nobody was sure whether the problem was technique, the tubes themselves, or the courier run. That is not a measurable problem statement.
The first move was to define the numerator and the denominator. A clotting rejection is any citrate tube that the laboratory rejects because a clot is present. The denominator is every citrate tube drawn in the same period, whether or not it was rejected. Dividing the first by the second gives a rejection rate that can be compared across quarters — and that single step converted a recurring argument into a number.
How Was the Rate Measured?
The clinic counted citrate tubes drawn and citrate tubes rejected for clotting over two consecutive quarters, tracking them by draw station rather than by individual phlebotomist, so the data would describe the process rather than a person. The self-reported results looked like this:
| Quarter | Citrate tubes drawn | Rejected for clotting | Rejection rate |
|---|---|---|---|
| Baseline quarter | 2,400 | 168 | 7.0% |
| Review quarter | 2,560 | 64 | 2.5% |
Two details make the comparison honest. The review quarter had slightly more draws, so the denominator grew; a fixed rejection count would have looked like an improvement while the rate stood still. And the rate was reported to one decimal place, deliberately, because the sample is modest and reporting to three decimals would imply precision the data does not carry.
The arithmetic behind the headline: 168 ÷ 2,400 = 7.0% at baseline, and 64 ÷ 2,560 = 2.5% after the changes, a fall of 4.5 percentage points and 104 fewer rejections across the quarter. Put differently, the clinic went from roughly seven rejected tubes in every hundred to roughly two and a half.
What Causes a Citrate Tube to Clot Before It Reaches the Lab?
Citrate tubes are unforgiving for a structural reason: the tube holds a fixed volume of liquid citrate anticoagulant and is designed to be filled to a marked line, so that the ratio of blood to anticoagulant lands where the method expects it. Anything that pushes the sample outside that design produces a result the laboratory cannot use, and clotting is one of the visible outcomes.
The causes that turned up in this review were not exotic. They fall into four groups:
- Underfilled tubes. A short draw leaves too much anticoagulant for the volume of blood collected, and the sample sits outside its design point. This was the largest single contributor in the review.
- Insufficient mixing. Tubes have to be mixed immediately and gently after the draw, because the anticoagulant has to reach the whole sample. A tube set down on the tray while the phlebotomist labels something else is a tube that did not get mixed at the right moment.
- Draw-order and line issues. Where a winged blood collection set is used, the tubing holds a dead volume, and the first tube in the sequence can be affected by it. The standard practice is a discard tube before the citrate tube when the setup requires one. Order of draw is not a habit; it is part of the method.
- Storage and transport. Tubes that sit in a warm vehicle, roll loose in a bag, or wait too long before reaching the laboratory add avoidable risk to an already fragile sample.
| Root cause observed | What it looked like on the floor | Change made |
|---|---|---|
| Short draw | Tube left visibly below the fill line and sent anyway | Fill-to-line check before the tube leaves the chair |
| Missed or delayed mixing | Tube placed on the tray, mixed later or not at all | Gentle inversion immediately at the chair, before anything else |
| Dead volume in the line | Citrate tube drawn first from a winged set | Discard tube used first where the setup requires it |
| Transport conditions | Tubes loose in a bag with other paperwork | Rigid transport with specimen bags, single handling |
Which Changes Moved the Number?
Four changes were made, and the review is honest that they were made together, so the clinic cannot attribute the improvement to any one of them with confidence. What it can say is that the combination moved the rate, and that three of the four cost nothing at all.
A fill-to-line check at the chair. No tube leaves the draw station below its marked line. Where a short draw happens, the tube is redrawn rather than sent "to see if it is acceptable", which was the habit the baseline count exposed.
Mixing at the moment of the draw. Inversion happens immediately, before labelling, before the next tube, before anything else. This reads like a small detail and it was the change staff resisted most, because it slows the sequence by seconds per tube.
A discard tube where the setup calls for one. Where a winged set is used, the dead volume is flushed into a separate tube so that the citrate tube receives the sample it was designed for.
Transport. Tubes were moved from a loose bag into rigid handling with specimen transport bags, which reduced movement in transit. The clinic uses 95 kPa 6 x 9 inch specimen bags, 100 pack for the primary pouch and 6 x 9 inch three-wall specimen transport bags, 100 pack where a three-wall pouch is preferred, so that the sample stays contained and does not travel loose with paperwork.
The setup work that supports this is set out in the site's guide to blood draw tray setup for Canadian clinics, and the stocking list behind it sits in the phlebotomy supply checklist. Rejection review as a discipline is covered in the worked example of cutting specimen rejections.
What Should a Clinic Track Afterward?
Four things, on a single sheet, updated monthly:
- Rejection rate by tube type. Citrate tubes are not the only fragile tube. Track the rate for every tube type so improvement in one does not hide deterioration in another.
- Rejection reason in plain words. Clotted, underfilled, mislabelled and haemolysed are different problems with different causes, and lumping them together hides which one to fix.
- Repeat draw count. The rejection rate is the process measure; the number of patients who had to be re-pricked is the human measure that gets a change funded.
- Per-station rather than per-person. Data that names individuals gets defended against. Data that names stations gets acted on.
The clinic's own reading of the result is that the number that mattered most was not the headline rate but the fill-to-line check, because it removed a whole class of borderline tubes that had been generating the argument in the first place. That conclusion is the clinic's own, drawn from a single quarter of self-reported data, and it is offered here as a method rather than as a general finding.
Related reading
- Blood draw tray setup for Canadian clinics
- Cutting specimen rejections: a worked example
- For clinics collection
Ordering for a clinic, lab or care home? Wholesale and multi-site ordering covers case pricing and account setup, and the B2B wholesale collection lists the lines stocked for institutional buyers.
Frequently Asked Questions
Why do citrate tubes clot more often than other tubes?
Because a citrate tube holds a fixed volume of liquid anticoagulant and is designed to be filled to a marked line, so the blood-to-anticoagulant ratio has to land where the method expects it. A short draw, delayed mixing or a dead-volume problem pushes the sample outside that design and clotting becomes visible.
Is a discard tube always needed before a citrate tube?
Not in every setup. Where a winged collection set is used, the tubing holds a dead volume and a discard tube flushes it so the citrate tube receives the sample it was designed for. Follow the order-of-draw practice for the collection device in use.
What is a reasonable citrate tube rejection rate?
There is no single number that applies to every clinic, because the denominator depends on case mix, staffing and equipment. The useful approach is to measure your own baseline quarter, change one or two things, and compare the next quarter against it.
Where should clotted tube rejections be documented?
In the same log as every other rejection, with the reason written in plain words and the draw station recorded rather than the individual. That gives you a process measure you can act on and a repeat-draw count that shows the benefit to patients.
CliniEco Medical is a licensed medical device establishment (MDEL #35334).
0 commentaire